Drug Type Autologous CAR-T |
Synonyms BMS 986453, BMS986453 |
Target |
Mechanism BCMA modulators(B-cell maturation protein modulators), GPRC5D modulators(G-protein coupled receptor family C group 5member D modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 1 | US | 23 Jan 2024 | |
Multiple Myeloma | Phase 1 | FR | 23 Jan 2024 | |
Multiple Myeloma | Phase 1 | DE | 23 Jan 2024 | |
Multiple Myeloma | Phase 1 | ES | 23 Jan 2024 |